The research could help doctors optimise the choice, timing, dose and sequence of antibiotics used to treat common infections, helping to halt the growing threat of antibiotic resistance to modern medicine.

Oil India Limited, a Navratna Public Sector Undertaking is the pioneer and second largest national upstream Oil and Gas Company with a pan India presence and growing global footprint. OIL is set to conquer newer horizons of all-round growth and excellence. It is engaged in exploration, production and transportation of crude oil, natural gas and production of LPG with its Field Headquarters (FHQ) at Duliajan, Dibrugarh, Assam. OIL has operations in Assam, Arunachal Pradesh, Andhra Pradesh, Odisha, Rajasthan, Mizoram and offices in Kolkata, Guwahati, Noida.

Applications are invited from eligible persons on contract basis only for six months only for the following posts in Government Maternal Health Hospital, Chennai to carry out Covid-19 Disaster and Corona Disease Prevention Works.

Post : Pharmacist

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state of art of R&D wing of the Tata Memorial Centre.

Centre for Cellular and Molecular Platforms, is a Dept. of Biotechnology (Govt. of India) initiative and a not for profit organization based in Bangalore. We act as an enabler of Bioscience Research, Innovation and Entrepreneurship by providing Research, Development, Training and Services in State Of The Art Technology Platforms.

Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram is an Institute of National Importance  established by an Act  of the Indian Parliament  and  under the 2 administrative control of the Department of Science and Technology, Government of India.

Indian Institute of Science Education and Research Mohali envisions a new generation of scientists dedicated to the pursuit of knowledge in  frontier areas of basic sciences. In an intellectually vibrant academic environment, IISER Mohali nurtures the basic tenets of science education and research at undergraduate and postgraduate levels. In so doing, the institute aims to emerge as a global centre of learning, academic excellence, and innovative research.

Regional Centre for Biotechnology is an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu.

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Executive QA ONCO

GlaxoSmithKline Pharmaceuticals Ltd is one of the oldest pharmaceuticals company and employs over 5000+ people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders.

Post : Assistant Manager - Warehouse

BDR Pharma gets license pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.

Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild to severe COVID-19 patients.

Applications are invited for contract basic services in Thoothukudi District Government Hospitals.

Post : Pharmacist

Applications are invited from the following eligible persons to work as Pharmacist on contract basis for 6 months in Government Hospitals under the control of Co-Director Welfare Office, Thiruvarur, during Covid-19 pandemic.

Post : Pharmacist

USP is proud to be an equal opportunity/affirmative action employer. Employment selection and related decisions are made without regard to sex, gender identity, race, age, disability, religion, national origin, color, veteran status or any other protected class. We are committed to working with and providing reasonable accommodation to individuals with disabilities.

Post : Scientist II, CDL

The Indian Army promises both professional and personal growth at every stage of the career. Opportunities to excel through various courses are abundant including opportunities to enhance your educational qualification by availing two years paid study leave. The inherent adventure and extra-curricular activities in the Army ensure an all round development essential in todays world. Art of War Engineering Medicine Administration Human Resource Development and Management; the army teaches you all.

VIDARBHA INSTITUTE OF PHARMACY are committed to offer the best in class academic services to the students and institutes to enhance the delight of industry and society. This will be achieved through continual improvement in management practices adopted in the process of curriculum design, development, implementation, evaluation and monitoring system along with adequate faculty development programs.

Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka, India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Saniona a clinical stage biopharmaceutical company focused on rare diseases announced that the U.S. Food and Drug Administration has granted orphan drug designation to Tesomet for the treatment of hypothalamic obesity. Tesomet is the first and only investigational treatment for HO to receive orphan drug designation. Saniona is preparing to initiate two Phase 2b studies of Tesomet in the second half of this year, one in HO and the other in Prader-Willi syndrome, for which Tesomet has already received orphan drug status.

Zydus Cadila has received tentative approval from the USFDA to market Ibrutinib Tablets, in the strengths of 140 mg, 280 mg, 420 mg and 560 mg. Ibrutinib belongs to a class of drugs known as kinase inhibitors and is used to treat certain cancers, such as mantle cell lymphoma or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and Waldenstrom's macroglobulinemia.